Bigul

SMS Lifesciences India Ltd - 540679 - Clarification (Price Movement)

Enclosed is a clarification letter for sudden movement in price of securities of SMS Lifesciences India Limited.
30-10-2021
Bigul

SMS Lifesciences India Ltd - 540679 - Reclassification Of Promoters (Application Submitted)

Company has submitted an application to Stock Exchange (s) today [i.e. October 27. 202 1), for reclassification of the promoters seeking reclassification from "Promoter Group" category to "Public" category, pursuant Regulation 31 A of SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015.
27-10-2021
Bigul

SMS Lifesciences India Ltd - 540679 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2021, as received from M/s. Aarthi Consultants Private Limited, the Registrar and Share Transfer Agent (RTA) of the Company.
13-10-2021
Bigul

SMS Lifesciences India Ltd - 540679 - Shareholding for the Period Ended September 30, 2021

SMS Lifesciences India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
12-10-2021
Bigul

SMS Lifesciences India Ltd - 540679 - Statement Of Investor Complaints For The Quarter Ended September 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Trupti Ranjan MohantyDesignation :- Company Secretary and Compliance Officer
12-10-2021
Bigul

SMS Lifesciences India Ltd - 540679 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

SMS Lifesciences India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
01-10-2021
Bigul

SMS Lifesciences India Ltd - 540679 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Outcome of 15th Annual General Meeting held on September 30, 2021.
01-10-2021
Bigul

SMS Lifesciences India Ltd - 540679 - Update On Subsidiary (Mahi Drugs)

Mr. Venkata Chaitanya Gopineedi has been appointed as Director in the Board of the Mahi Drugs Private Limited (wholly owned subsidiary of the Company), in the Executive category, in the 9''" Annual General Meeting held today (i.e. September 28, 2021).
28-09-2021
Bigul

SMS Lifesciences India Ltd - 540679 - Closure of Trading Window

Trading Window for dealing in securities of the Company shall remain closed with effect from October 1, 2021 till 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2021 (hereinafter referred as 'Window Closure Period') in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
28-09-2021
Bigul

SMS Lifesciences India Ltd - 540679 - Reg. 34 (1) Annual Report

Copy of Annual Report for the year ended March 31, 2021.
08-09-2021
Next Page
Close

Let's Open Free Demat Account